Nurse Practitioner · Tampa, FL
NPI
1942591854
Since 2011
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (888) 860-2778
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
473 services
Medicare patients, 2024
285
Average age 74
Drug cost, 2024
$5.4M
574 prescriptions
Company payments, 2025
$17K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa A Nodzon was code 99214 (office e&m - established), 250 times for 178 patients. In total Lisa A Nodzon billed 473 services in 7 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 250 | 178 | $53.46 | $13K |
| 99213 Office E&M - Established | Facility | 77 | 75 | $42.55 | $3,276 |
| 99213 Office E&M - Established | Office | 52 | 44 | $59.76 | $3,107 |
| 99205 Office E&M - New | Facility | 39 | 39 | $98.20 | $3,830 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 23 | 13 | $11.02 | $253 |
| 99214 Office E&M - Established | Office | 15 | 15 | $83.11 | $1,247 |
By year: 2022 $27K for 429 services; 2023 $25K for 400 services; 2024 $26K for 473 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lisa A Nodzon prescribed most often to Medicare patients was Imbruvica (Ibrutinib), with 109 prescriptions and refills. In total Lisa A Nodzon wrote 574 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imbruvica Ibrutinib | 109 | 109 | 13 | $1.5M |
| Calquence Acalabrutinib Maleate | 102 | 102 | 17 | $1.5M |
| Acyclovir Generic | 64 | 154 | 20 | $1,467 |
| Allopurinol Generic | 38 | 78 | 18 | $360 |
| Tasigna Nilotinib Hcl | 35 | 35 | Under 11 | $302K |
| Brukinsa Zanubrutinib | 34 | 34 | Under 11 | $390K |
| Bosulif Bosutinib | 33 | 33 | Under 11 | $571K |
| Venclexta Venetoclax | 24 | 24 | Under 11 | $342K |
| Sprycel Dasatinib | 17 | 17 | Under 11 | $138K |
Brand drugs: 380 claims; generic drugs: 194 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lisa A Nodzon $17K ($17K in general payments such as food, travel and fees) from 6 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $9,879.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.